Clinical trials
Recruiting Phase 1 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 4 |
| 2025 | 12 |
| 2026 | 43 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 14 |
| Eli Lilly and Company | 6 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Gan & Lee Pharmaceuticals. | 3 |
| Shanghai Minwei Biotechnology Co., Ltd | 3 |
| Beijing QL Biopharmaceutical Co.,Ltd | 2 |
| Columbia University | 2 |
| Laekna Limited | 2 |
| Beijing Suncadia Pharmaceuticals Co., Ltd | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 59 |
| Obesity | 57 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus, Type 1 | 3 |
| Insulin Resistance | 3 |
| Fatty Liver | 2 |
| Hyperinsulinism | 2 |
| Prediabetic State | 2 |
| Body Weight | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.